Condition
Chordoma clinical trials and research
Research outlook What's coming for Chordoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 8 Chordoma clinical trials that are recruiting, at sites in 12 countries (most in United States (4), Netherlands (2), Spain (2)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 12Countries
Newest Chordoma clinical trials
All recruiting trials (8)
-
Combination treatment of pembrolizumab and high-dose pemetrexed for chordoma
This study is testing a new combination of two drugs, pembrolizumab and high-dose pemetrexed, to see if it can help people with progressive chordoma, a rare cancer.
-
Alpha/beta T‑Cell and B‑Cell Depletion plus Zoledronic Acid for Pediatric and Young Adult Solid Tumors
This study will try removing alpha/beta T cells and B cells from donor stem cell grafts and giving zoledronic acid to see if it helps children and young adults (6 months to 25 years) with relapsed or high‑risk solid tumors tolerate allogeneic transplant and reduce relapse.
-
Comparing single vs double beam proton therapy for certain tumors
This study is testing whether using one beam of proton therapy is just as effective and safer than using two beams for patients with certain types of tumors.
-
Proton therapy for chordomas and chondrosarcomas at the skull base
This study is testing a new type of proton therapy to see if it can effectively treat chordomas and chondrosarcomas at the base of the skull while keeping side effects low and improving patients' quality of life.
-
Comparing carbon ion therapy, surgery, and proton therapy for pelvic bone sarcomas
This study is testing whether carbon ion therapy works better than surgery or proton therapy for treating pelvic bone sarcomas and how these treatments affect patients' quality of life.
-
Using imaging to improve proton therapy for chordomas and chondrosarcomas
This study is testing if using advanced imaging techniques can help improve proton therapy for patients with aggressive bone tumors called chordomas and chondrosarcomas by better targeting the tumors and protecting healthy tissue.
-
Observing the natural history of chordoma in children and adults
This study is trying to learn more about how chordoma, a rare bone cancer, affects children and adults by tracking their health and treatment responses over time.
-
Comparing surgery and radiation therapy for sacral chordoma treatment
This study is testing whether surgery or radiation therapy works better for treating sacral chordoma in patients who have this localized tumor.
Related topics
Quick answers
How many Chordoma clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (4 trials), Netherlands (2 trials), Spain (2 trials), France (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.